Content reuse is the practice of creating one piece of content and then using that piece of content everywhere you need it. A reused piece of content is created, finalized, translated, managed, stored, and retired one, and only one, time.
In pharmaceutical and biotech regulatory document development, your content strategy – the business plan for how you create, manage, and deliver content – significantly impacts your ability to innovate, comply with regulations, and ultimately, bring new medicines to market.
Content automation is the practice of using systems to perform repetitive tasks to create content; such as formatting, data retrieval, and document assembly. Content automation in the pharmaceutical industry is often implemented for the following reasons:
The following guidelines will help you build your skills and deepen your understanding of why structure requires us to change how we write.
Discover how structured content transforms healthcare by breaking down barriers in standard response documents, enabling healthcare professionals to access and deliver relevant, current, and findable information, ultimately improving patient outcomes.
Learn about the importance of standardized and personalized content to ensure cohesive information flow and explore the Content Rules framework for content standardization.
Pharma companies are under pressure to improve the quality and efficiency of their content. Learn how to select your first SCA use case.
By treating content as data, rather than documents, most of the problems inherent in monolithic documents are remedied.